Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ivy Animal Health was a specialized pharmaceutical company focused on the development and manufacturing of products for the livestock industry, particularly cattle and swine. The company was widely recognized for its "Component" line of cattle growth implants, which utilized advanced delivery technology to improve feed efficiency and weight gain in beef cattle. Headquartered in Overland Park, Kansas, Ivy established a strong market presence through technical innovation and strategic partnerships with distributors like VetLife. In 2007, the company was acquired by Eli Lilly and Company and integrated into its Elanco Animal Health division, significantly strengthening Elanco's portfolio in the livestock productivity sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ivy Animal Health.